Finance

Beta
Lists
H6D0:FRA
Haleon PLC
€3.82
+0.47%
(+0.018) 1D
Jun 5, 9:55:01 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for H6D0...
Open
€3.76
High
€3.82
Low
€3.76
Mkt. cap
29.56B
Avg. vol.
736.00
Volume
0.00
52-wk high
€4.86
52-wk low
€3.66
No. of employees
25K
Open
€3.76
High
€3.82
Low
€3.76
Mkt. cap
29.56B
Avg. vol.
736.00
Volume
0.00
52-wk high
€4.86
52-wk low
€3.66
No. of employees
25K
News stories
From sources across the web
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022. Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC
CEO-
Employees24.5K
FoundedJul 18, 2022
Headquarters-
SectorPharmaceutical industry
Websitehaleon.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.74B
2.74B
2.78B
2.78B
Cost of goods sold
972.50M
972.50M
970.50M
970.50M
Cost of revenue
972.50M
972.50M
970.50M
970.50M
Research and development expenses
76.00M
76.00M
81.50M
81.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.08B
1.08B
1.08B
1.08B
Operating expense
1.16B
1.16B
1.16B
1.16B
Total operating expenses
2.13B
2.13B
2.13B
2.13B
Operating income
608.50M
608.50M
643.00M
643.00M
Other non operating income
500.00K
500.00K
-10.50M
-10.50M
EBT including unusual items
537.50M
537.50M
538.50M
538.50M
EBT excluding unusual items
544.50M
544.50M
552.00M
552.00M
Income tax expense
131.00M
131.00M
105.00M
105.00M
Effective tax rate
24.37%
24.37%
19.50%
19.50%
Other operating expenses
-
-
-
-
Net income
403.00M
403.00M
430.50M
430.50M
Net profit margin
14.71%
14.71%
15.51%
15.51%
Earnings per share
-
-
-
-
Interest and investment income
23.50M
23.50M
5.00M
5.00M
Interest expense
-88.00M
-88.00M
-85.50M
-85.50M
Net interest expenses
-64.50M
-64.50M
-80.50M
-80.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
667.00M
667.00M
704.50M
704.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer